MICHAEL JOSEPH POIESZ (M.D.) – Medical Oncology Physician, NPI 1952528762
Medical Oncology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
380 MEDICAL ONCOLOGY in FL
Provider Addresses for MICHAEL JOSEPH POIESZ (M.D.)
601 Redstone Ave W Ste 200
Crestview, FL 325366439
Phone: (850) 201-2420
Fax: (850) 886-2099
Type: Location
161 E Nine Mile Rd # 100
Pensacola, FL 325343140
Phone: (850) 201-2422
Fax: (850) 886-2229
Type: Location
4724 N DAVIS HWY
PENSACOLA, FL 325032339
Phone: (850) 696-4000
Fax: (850) 434-2647
Type: Mailing
4724 N Davis Hwy # 100
Pensacola, FL 325032339
Phone: (850) 201-2421
Fax: (850) 886-2235
Type: Location
1301 Belleville Ave
Brewton, AL 364261306
Phone: (850) 201-2419
Fax: (251) 930-6028
Type: Location
PO BOX 102222
ATLANTA, GA 303682222
Phone: (239) 274-8200
Type: Mailing
4724 N DAVIS HWY # 100
PENSACOLA, FL 325032339
Phone: (850) 201-2421
Fax: (850) 886-2235
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 32 Open Payments records for all available years, with a total value of $677.
Total Amount is formed as General ($677) + Research ($0) + Ownership ($0) = $677.
Last reported payment date: 2024-11-21 • Largest payer in this snapshot: Novartis Pharmaceuticals Corporation ($79).
Total Amount
$677
General + Research + Ownership
Payments
32
Total payment records
General Amount
$677
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-11-21
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Novartis Pharmaceuticals Corporation | $79 |
| Mirati Therapeutics, Inc. | $78 |
| ABBVIE INC. | $50 |
| PFIZER INC. | $36 |
| Celgene Corporation | $33 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2018-10-31
PECOS data refreshed: 2026-06-15
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking 2 Medicare enrollment records; no due dates published yet.
Enrollment records
2
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20140927000084 | I | Medical Oncology | FL | TBD |
| I20181031003393 | I | Hematology/Oncology | AL | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 30,180 | 14 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 19,400 | 35 | $0 |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 16,320 | 24 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 9,138 | 23 | $0 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 9,050 | 29 | $0 |
Insurance plans in this area (ZIP 32536)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| HEMATOLOGY/ONCOLOGY | FL | 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 88 | 14 |
Group practice members
| Name | Specialty | State |
|---|---|---|
| U R O L O G Y | FL | |
| Nurse Practitioner | GA | |
| Physician Assistant | GA | |
| Family Practice | TX | |
| Hematology, Medical Oncology, Hematology/Oncology | FL | |
| Internal Medicine | FL | |
| U R O L O G Y | FL | |
| U R O L O G Y | AL | |
| Family Practice | FL | |
| Nurse Practitioner | GA |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.